Difference between revisions of "Neuroscience"
From PiWiki
| Line 4: | Line 4: | ||
:"Recent studies have uncovered two distinct types of regulatory mechanisms that differentiate dendritic and axonal growth: '''dedicated''' mechanisms and '''bimodal''' mechanisms. '''Dedicated''' mechanisms regulate either dendrite- specific or axon-specific growth; in contrast, '''bimodal''' mechanisms direct dendritic and axonal development in '''opposite''' manners." | :"Recent studies have uncovered two distinct types of regulatory mechanisms that differentiate dendritic and axonal growth: '''dedicated''' mechanisms and '''bimodal''' mechanisms. '''Dedicated''' mechanisms regulate either dendrite- specific or axon-specific growth; in contrast, '''bimodal''' mechanisms direct dendritic and axonal development in '''opposite''' manners." | ||
| + | : | ||
| + | :[[File:Neurite_Regulators.png]] | ||
<blockquote>[https://en.wikipedia.org/wiki/Category:Quotation_templates]</blockquote> | <blockquote>[https://en.wikipedia.org/wiki/Category:Quotation_templates]</blockquote> | ||
| + | |||
| + | |||
Revision as of 23:14, 9 September 2014
(2014) Regulatory mechanisms underlying the differential growth of dendrites and axons
Media:2014_--_Regulatory_mechanisms_underlying_the_differential_growth_of_dendrites_and_axons.pdf
- "Recent studies have uncovered two distinct types of regulatory mechanisms that differentiate dendritic and axonal growth: dedicated mechanisms and bimodal mechanisms. Dedicated mechanisms regulate either dendrite- specific or axon-specific growth; in contrast, bimodal mechanisms direct dendritic and axonal development in opposite manners."
[1]
Shrooms
Potentiation of neuritogenic activity of medicinal mushrooms in rat pheochromocytoma cells
DIHEXA
Ashwagandha
Axon (or dendrite) predominant outgrowth induced by constituents from Ashwagandha
- "results suggest that axons are predominantly extended by withanolide A, and dendrites by withanosides IVand VI."
Media:2002_--_Axon-_or_dendrite-predominant_outgrowth_induced_by_constituents_from_Ashwagandha.pdf
- withanoside IV a.k.a. Sominone = GDNF-independent stimulator of the RET pathway and/or a novel modulator of RET signalling
